Gene therapy patients monitored for 5 years after bladder treatment
Disease control
Not yet recruiting
This study follows 16 people for five years after they received an experimental gene therapy called EG110A for bladder control problems caused by spinal cord injury. Researchers want to understand the long-term safety of this treatment and see how long its benefits last. Particip…
Phase: PHASE1, PHASE2 • Sponsor: EG 427 • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC